The Effect of Guided Web-Based Cognitive Behavioral Therapy on Patients With Depressive Symptoms and Heart Failure: A

Johan Gustav Lundgren1, Örjan Dahlström, Gerhard Andersson

  • 1Division of Nursing Science, Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden. johan.lundgren@liu.se.

Insights

Internet-based cognitive behavioral therapy (ICBT) showed a significant reduction in depressive symptoms for heart failure patients, though not superior to a discussion forum. Patient engagement with the ICBT platform correlated with symptom improvement.

Area of Science:

  • Cardiology
  • Psychiatry
  • Digital Health

Background:

  • Depressive symptoms, anxiety, and reduced quality of life (QoL) are prevalent in heart failure (HF) patients.
  • Effective treatment strategies for depression in HF are needed.
  • Internet-based cognitive behavioral therapy (ICBT) is a promising approach for depression.

Purpose of the Study:

  • To evaluate the efficacy of a 9-week guided ICBT program on depressive symptoms in HF patients.
  • To assess the impact of ICBT on cardiac anxiety and QoL.
  • To identify factors associated with changes in depressive symptoms.

Main Methods:

  • Fifty HF patients were randomized to ICBT or a web-based discussion forum (DF).
  • Depressive symptoms, cardiac anxiety (CAQ), and QoL were measured at baseline and follow-up.
  • Intention-to-treat analysis with imputation for missing data was performed.

Main Results:

  • No significant between-group difference in depressive symptoms was found.
  • Within the ICBT group, depressive symptoms significantly decreased (P=.02).
  • Cardiac anxiety showed a significant decrease in the ICBT group (P=.04); higher engagement correlated with symptom improvement.

Conclusions:

  • Guided ICBT was not statistically superior to a web-based DF for HF patients with depressive symptoms.
  • A significant within-group improvement in depressive symptoms was observed in the ICBT group.
  • Patient engagement and certain demographic factors influenced treatment outcomes.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
470
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
648
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.4K